Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

Author(s):  
Yuping Chen ◽  
Hesong Wu ◽  
Tao Yang ◽  
Guanshan Zhou ◽  
Yuyin Chen ◽  
...  

2017 ◽  
Vol 5 (35) ◽  
pp. 7342-7351 ◽  
Author(s):  
Ilknur Erucar ◽  
Seda Keskin

The potential of metal organic frameworks (MOFs) as binary drug carriers was computationally investigated for storage and delivery of two anticancer drug molecules, methotrexate (MTX) and 5-fluorouracil (5-FU).





Molecules ◽  
2018 ◽  
Vol 23 (10) ◽  
pp. 2490 ◽  
Author(s):  
Xin Leng ◽  
Xiaoxv Dong ◽  
Wenping Wang ◽  
Na Sai ◽  
Chunjing Yang ◽  
...  

Sustained-release preparation is a hot spot in antitumor drug research, where the first task is to select suitable drug carriers. Research has revealed that carboxylic acid iron metal–organic frameworks (MOFs), constructed from iron (Fe) ions and terephthalic acid, are nontoxic and biocompatible. Due to the breathing effect, the skeleton of this mesoporous material is flexible and can reversibly adapt its pore size through drug adsorption. Therefore, we chose one kind of Fe-MOF, MIL-53(Fe), as a carrier for the anticancer drug oridonin (Ori). In this work, we report the design and synthesis of MIL-53(Fe) and explore its ability as a transport vehicle to deliver Ori. MIL-53(Fe) is characterized by scanning electron microscopy and X-ray powder diffraction. A loading capacity of 56.25 wt % was measured by high performance liquid chromatography. This carrier was safe and nontoxic (cell viability > 95.27%), depending on the results of 3-(4,5-dimethylthiazol-2-yl)--2,5-diphenyltetrazolium bromide assays, lactate dehydrogenase assays, and Annexin V-fluoresce isothiocyanate/propidium iodide double-staining assays. After loading the drug, the structure of the MIL-53(Fe) was not destroyed, and Ori was amorphous in MIL-53(Fe). Based on an analysis of the Ori release profile, results suggest that it lasts for more than seven days in vitro. The cumulative release rate of Ori at the seventh day was about 82.23% and 91.75% in phosphate buffer saline solution at 37 °C under pH 7.2 and pH 5.5, respectively. HepG2 cells were chosen to study the cytotoxicity of Ori@MIL-53(Fe), and the results show that the anticancer ratio of Ori@MIL-53(Fe) system reaches 90.62%. Thus, MIL-53 can be used as a carrier for anticancer drugs and Ori@MIL-53(Fe) is a promising sustained-release drug delivery system for the cancer therapy.



Author(s):  
Yi Guan ◽  
Nan Li ◽  
Jiao He ◽  
Yongliang Li ◽  
Lei Zhang ◽  
...  

Herein, we report a post-assembly strategy by growing the bimetallic Co/Zn zeolitic imidazolate frameworks (BIMZIF) on the surface of the customized Mo metal-organic frameworks (MOFs) (Mo-MOF) to prepare the core-shell...



2021 ◽  
Author(s):  
Yingxue Tu ◽  
Caifen Lei ◽  
Fei Deng ◽  
Yiang Chen ◽  
Ying Wang ◽  
...  

Metal organic frameworks (MOFs) have the potential to boost the undervalued biomedical applications of metal ions. Such endeavor has been hindered by the challenge of how to avoid the (cyto)toxicity...





AIChE Journal ◽  
2021 ◽  
Author(s):  
Jiaqi Liu ◽  
Zhen Yang ◽  
Yuanyuan Che ◽  
Yaojie Zhang ◽  
Zhihao Zhang ◽  
...  


2014 ◽  
Vol 2 (7) ◽  
pp. 766-774 ◽  
Author(s):  
María C. Bernini ◽  
David Fairen-Jimenez ◽  
Marcelo Pasinetti ◽  
Antonio J. Ramirez-Pastor ◽  
Randall Q. Snurr


Author(s):  
Qing Xu ◽  
Minghao Liu ◽  
Qiyang Miao ◽  
Shuai Yang ◽  
Ping Wu ◽  
...  

Constructing heterostructures of covalent organic frameworks (COFs) and metal organic frameworks (MOFs) have gained great attention for various applications due to their well-defined skeletons, ordered porosity and designable functions. Herein,...



Sign in / Sign up

Export Citation Format

Share Document